Regenerative Medicine has the potential to heal or replace tissues and organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Since the inception of the field several decades ago, a number of regenerative medicine therapies, including those designed for wound healing and orthopedic applications, have received Food and Drug Administration (FDA) approval/clearance and are now commercially available. The delivery of therapeutic cells that directly contribute to the structure and function of new tissues is a principle paradigm of regenerative medicine to date. The cells used in these therapies are either autologous or allogeneic. Autologous uses a person’s own stem cells and allogeneic uses cells from a donor.
At Physical Healthcare of Jacksonville, we specialize in Allogeneic Cell Therapy and Acellular Recruitment Therapy, also known as Stem Cell Recruitment Therapy™.
Allogeneic Cell Therapy, also known as Regenerative Cell Therapy, is an area of healthcare that has the potential to have a disruptive effect on the way certain human ailments and conditions are treated. Allogeneic cell and tissue allografts are able to supplement the body’s natural healing process.
Allogeneic Cell Therapy uses a cell and tissue allograft that is comprised of growth factors, cytokines, proteins, and mesenchymal stem cells to prevent and treat health conditions, disease and chronic pain. We utilize this type of Regenerative Cell Therapy in our clinic because we have found through research and our actual patient outcomes that it is more effective on joint and ligament conditions and/or deterioration as opposed to autologous stem cell therapies utilizing adipose tissue (fat) or bone marrow. We also prefer this method of Regenerative Cell Therapy because it is far less invasive on the patient.
As our bodies age we experience longer healing times, inflammation, and cell exhaustion (cell aging). Over time, healthy tissue can become dysfunctional, not only due to age, but injury as well. We administer our cell and tissue allograft to the recipient’s area of injury or degeneration such as the knee, neck, spine, or shoulder to help repair, reconstruct, replace, or supplement the same basic functions of the recipient’s cells or tissues.
The procedure takes less than 15 minutes with minimal pain and is extremely safe and effective.
The human body utilizes a variety of tissue and cell interactions to support the healing process. Our cell and tissue allografts supplement similar tissue in your body via scaffolding, growth factors, homeostatic and general cytokines.
10-year NFL veteran, 8-year Jacksonville Jaguar and two-time Pro Bowler “Big” John Henderson received regenerative cell therapy in his back and both knees. His results have been phenomenal – Big John was able to avoid surgery and get rid of his wheelchair!
Patients with bone, joint, and ligament conditions/injuries including:
• Back Pain • Facet Syndrome • Degenerative Disc Disease • Lumbar Arthritis • Osteoarthritis • Bursitis • Cervical Pain • Cervical DJD • Cervical Arthritis • Carpal Tunnel Syndrome • Wrist Arthritis • Tennis Elbow • Golfer’s Elbow • Bicep Tendon Tear • Shoulder Degeneration and Arthritis • Shoulder Injuries • Rotator Cuff Tears • Hip Pain • Labrum Tear • Hip Osteoarthritis • Hip Degeneration • Hip Bursitis • Meniscus Tear • Knee Degeneration • ACL or PCL Injury • Chondromalacia • Foot Pain • Plantar Fasciitis
The cell and tissue allograft we use are processed in an FDA registered lab. The cell and tissue allograft we use is minimally manipulated and prepared utilizing proprietary extraction methods that reduce the loss of important cytokines, growth factors, proteins, and biomolecules, and are intended for homologous use.
The cell and tissue allograft we use is processed from donated human tissue from full term deliveries. Comprehensive medical and social histories of the donors are obtained and tissues are procured, processed, and tested in accordance with standards established by FDA requirements to minimize potential risks of disease transmission to recipients. Infectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.
Acellular Recruitment Therapy or Stem Cell Recruitment Therapy™ is a revolutionary procedure to help rejuvenate and regenerate ailing joints, repair soft tissue damage, and increase mobility while decreasing pain.
By using a combination of growth factors and other endogenously synthesized molecules, these elements work together to recruit the body’s own stem cells and healing components to reconstruct and regenerate new, healthy tissue without surgery. It is administered through a single injection of Human Amniotic Fluid (AF).
Amniotic Fluid (obtained from an elective, full-term live cesarean section delivery) contains a rich mixture of collagens, cytokines, elastins and growth factors that creates an extracellular matrix which supports healing and has the potential to reduce pain & inflammation and contribute to the regeneration and reconstruction of injured tissue.
While cortisone and other drugs only provide temporary pain relief, amniotic fluid actually helps restore degenerated tissue while providing pain relief. The amniotic fluid helps to promote the body’s own healing process by directly mitigating the repair and the regeneration of healthy tissue. Additionally, amniotic fluid injections contain hyaluronic acid, which lubricates joints and tendons, easing the pain and helping restore mobility.
The treatment is ideal for patients suffering from the following:
An AF injection is a graft derived solely from pure amniotic fluid, obtained from an elective, full-term live cesarean section delivery. All donors provide consent and are screened per FDA/AATB guidelines. Amniotic fluid (AF) is a marvelously complex and dynamic milieu that changes as pregnancy progresses. AF contains nutrients and growth factors that facilitate fetal growth, provides mechanical cushioning and antimicrobial effectors that protect the fetus, and allows assessment of fetal maturity and disease.
Yes, Regenerative Medicine utilizes amniotic fluid and placental tissue products. These products are regulated and 361 compliant by the FDA. AF is considered a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/Ps).
Yes, amniotic fluid injections are covered by Medicare, TriCare, UH Medicare Advantage, Workers Comp and commercial insurances. Every insurance plan is different, so we will verify your insurance benefits to determine your coverage in our clinic.
The number of AF injections needed depends on the type and severity of your injury. Our providers will determine the number of injections you should receive and the best timeline.
For more information about Allogeneic Cell Therapy or Acellular Recruitment Therapy for joint, soft tissue, and spinal injuries, call us at 904-645-0777 to schedule a no-obligation consultation.